Innovative Food Holdings Q3 Revenue Falls 23.8% to $12.0M; Material Weaknesses Persist
IVFH sits 36% above its 52-week low of $0.131.
Summary
Q3 revenue fell 23.8% to $12.0 million and the company posted a $181,201 operating loss from continuing operations, while previously disclosed material weaknesses in internal controls remained unremediated as of September 30, 2026.
Updates
· GlobeNewswire — IVFH's Q3 2026 GAAP net loss from continuing operations was $181 thousand, or $(0.003) per diluted share, versus $651 thousand net income a year earlier.
Key Events · Earnings and Guidance · IVFH
-
Q3 Revenue Down 23.8%
Revenue fell to $11,951,720 from $15,676,898, with digital channels down 23.5%, national distribution down 30.6% and local distribution down 18.6%.
-
Swing to Operating Loss
Operating loss of $184,097 versus $663,361 of operating income a year earlier; net loss from continuing operations was $181,201 versus $650,599 income.
-
Profit Flattered by Asset Sale
Nine-month net income of $2,029,359 includes a $2,764,063 gain on the March 6, 2026 sale of the Mountain Top, Pennsylvania facility for $9,225,000.
-
Material Weaknesses Persist
Management concluded disclosure controls were not effective at September 30, 2026; IT general-control material weaknesses disclosed in the 10-K remain unremediated.
Analysis · IVFH · Trade & Services
The core specialty-food business is shrinking faster than costs are coming out: revenue dropped 23.8% to $11.95 million in Q3, and the company swung to a $181,201 operating loss from continuing operations versus $650,599 of income a year earlier. A nine-month net profit of $2.03 million is an accounting artifact of the $2.76 million gain on selling the Pennsylvania facility, not operating strength. Management also concluded disclosure controls were not effective as of September 30, 2026 because IT general-control material weaknesses previously disclosed in the 10-K remain unremediated, and it granted 1.65 million restricted shares to three executives on September 14, 2026. Cash of $1.66 million plus the assertion of twelve months of liquidity is the main offset, but the revenue trend and control gaps are the story.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IVFH was trading at $0.18 on OTC in the Trade & Services sector, with a market capitalization of approximately $9.8M. The 52-week trading range was $0.13 to $0.55. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.